Understanding Second-Line Treatments and Side Effects

Overall, treating JM aims to treat an overactive immune system. Ways to treat an inappropriately overactive immune system include the following: immunosuppression, or reducing the activity of the immune system, which comes with a risk of infection, and immunomodulation, or reducing the activity of the immune system. Medications for initial treatment or induction include steroids, methotrexate, hydroxychloroquine, IVIG, exercise, and sun protection.

Second-line medications that should be considered after the initial treatment period of treatments already discussed—either because the patient cannot tolerate these medications or the disease is still active.

Second-line treatments are sometimes considered alternatives, switching one out for another, and sometimes considered add-on therapy to eliminate the disease.

In this presentation, Dr. Curran and Dr. Kim explain second-line treatments and the side effects of each.

2022 Cure JM Medical Symposium

Juvenile Dermatomyositis: Advances in Basic Research, Translational Studies and Clinical care. Hosted by Duke University and Cure JM Foundation. March 12th, 2022.

Join Cure JM

Membership is free and we’ll connect you with a network of support, encouragement, and resources.

Cure JM supports families, patients, and the juvenile myositis research community.

Interested in DIY fundraising but need help?

We’re here to help!

To have your fundraiser matched, add “DIY Match” in the memo of your online gift or check.